- Home
- VRNA vs HQY Comparison
VRNA vs HQY Comparison
Compare VRNA & HQY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRNA
- HQY
- Stock Information
- Founded
- VRNA 2005
- HQY 2002
- Country
- VRNA United Kingdom
- HQY United States
- Employees
- VRNA N/A
- HQY N/A
- Industry
- VRNA Biotechnology: Pharmaceutical Preparations
- HQY Business Services
- Sector
- VRNA Health Care
- HQY Consumer Discretionary
- Exchange
- VRNA Nasdaq
- HQY Nasdaq
- Market Cap
- VRNA 8.3B
- HQY 7.9B
- IPO Year
- VRNA 2017
- HQY 2014
- Fundamental
- Price
- VRNA $105.79
- HQY $88.51
- Analyst Decision
- VRNA Buy
- HQY Strong Buy
- Analyst Count
- VRNA 11
- HQY 13
- Target Price
- VRNA $114.10
- HQY $116.77
- AVG Volume (30 Days)
- VRNA 1.4M
- HQY 914.3K
- Earning Date
- VRNA 08-06-2025
- HQY 09-02-2025
- Dividend Yield
- VRNA N/A
- HQY N/A
- EPS Growth
- VRNA N/A
- HQY 48.80
- EPS
- VRNA N/A
- HQY 1.37
- Revenue
- VRNA $221,673,000.00
- HQY $1,243,021,000.00
- Revenue This Year
- VRNA $896.59
- HQY $9.69
- Revenue Next Year
- VRNA $77.56
- HQY $8.89
- P/E Ratio
- VRNA N/A
- HQY $64.49
- Revenue Growth
- VRNA N/A
- HQY 19.21
- 52 Week Low
- VRNA $24.50
- HQY $73.84
- 52 Week High
- VRNA $105.89
- HQY $116.65
- Technical
- Relative Strength Index (RSI)
- VRNA 68.01
- HQY 39.64
- Support Level
- VRNA $105.23
- HQY $87.27
- Resistance Level
- VRNA $105.81
- HQY $90.00
- Average True Range (ATR)
- VRNA 0.25
- HQY 2.53
- MACD
- VRNA -0.36
- HQY 0.06
- Stochastic Oscillator
- VRNA 87.88
- HQY 10.01
About VRNA Verona Pharma plc
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.
About HQY HealthEquity Inc.
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.